about
Effects of yohimbine on the antinociceptive and place conditioning effects of opioid agonists in rodentsProteomic analysis of the nucleus accumbens of rats with different vulnerability to cocaine addiction.Differential phosphoproteome of the striatum from pleiotrophin knockout and midkine knockout mice treated with amphetamine: correlations with amphetamine-induced neurotoxicity.Phosphoproteomic analysis of the striatum from pleiotrophin knockout and midkine knockout mice treated with cocaine reveals regulation of oxidative stress-related proteins potentially underlying cocaine-induced neurotoxicity and neurodegeneration.Chronic Cocaine Use Causes Changes in the Striatal Proteome Depending on the Endogenous Expression of Pleiotrophin.Targeting midkine and pleiotrophin signalling pathways in addiction and neurodegenerative disorders: recent progress and perspectives.Behavioral and in vitro evaluation of tetrodotoxin tolerability for therapeutic applications.Functional neuroimaging of amphetamine-induced striatal neurotoxicity in the pleiotrophin knockout mouse model.Synthesis and biological evaluation of novel 2-(1H-imidazol-4-yl)cyclopropane carboxylic acids: key intermediates for H3 histamine receptor ligands.The contribution of alpha2-adrenoceptor and opioid receptor mechanisms to antinociception differs in Lewis and Fischer 344 rats.Regulation of extinction of cocaine-induced place preference by midkine is related to a differential phosphorylation of peroxiredoxin 6 in dorsal striatum.Genetic inactivation of midkine modulates behavioural responses to ethanol possibly by enhancing GABA(A) receptor sensitivity to GABA(A) acting drugs.Histamine H3 receptor desensitization in the guinea-pig ileum.The alpha2-adrenoceptor antagonist yohimbine reduces glial fibrillary acidic protein upregulation induced by chronic morphine administration.Bioactive properties of Tynanthus panurensis (Bureau) Sanwith bark extract, the Amazonian "clavo huasca".Assessing addiction vulnerability with different rat strains and place preference procedures: the role of the cocaine and amphetamine-regulated transcript.Genetic inactivation of pleiotrophin but not midkine potentiates clonidine-induced alpha-2 adrenergic-mediated analgesia.Morphine and yohimbine regulate midkine gene expression in the rat hippocampus.Yohimbine prevents morphine-induced changes of glial fibrillary acidic protein in brainstem and alpha2-adrenoceptor gene expression in hippocampus.Place conditioning in a two- or three-conditioning compartment apparatus: a comparative study with morphine and U-50,488.Subcutaneous tetrodotoxin and inflammatory pain.Pleiotrophin differentially regulates the rewarding and sedative effects of ethanol.Gene expression analysis of heat shock proteins in the nucleus accumbens of rats with different morphine seeking behaviours.Midkine regulates amphetamine-induced astrocytosis in striatum but has no effects on amphetamine-induced striatal dopaminergic denervation and addictive effects: functional differences between pleiotrophin and midkine.Effects of histamine H3 receptor ligands in experimental models of anxiety and depression.Elastic image registration of 2-D gels for differential and repeatability studies.
P50
Q28363862-E07D3A58-FBFE-4DAB-A7C7-98753F306EBFQ33434961-F2FEE8A4-5CFB-4002-8BC4-B1F8527DD31EQ34607829-FAF7027B-BDD8-4D39-9153-042636F45315Q35008461-11AA9576-E7D7-4E4A-8AC3-2C1310EE9698Q35653652-65D7B677-B897-4254-BDA1-79602FEDD3F9Q38124378-5938E8FA-6187-4C5E-B05E-7CC11AEAFC24Q39978795-46A801E8-3011-4763-9D0A-7A66D7FCA3CEQ41374554-AA7ACE08-DABE-45E1-A1A0-1F91F9B41558Q44223572-0C13EC9E-ED79-42FC-91A2-DD76421158B9Q44341098-5A4BFFEC-3A20-43CB-9DED-E9CFD63F2CF9Q45617714-D5F3BDE8-DEAD-4DEB-A83B-3C87ED385D7FQ46122706-4CCE789A-FDD7-4166-8676-19E3E7FC2F3CQ46151087-8475E858-3B94-4309-B8A3-06F39AE4F7B3Q46528535-F8D37F78-19F6-4713-9D9C-64913B25C7ACQ47306174-87F7910E-80CD-47A8-8FD1-597A41175BEDQ47879941-AB591364-8BA4-4584-8369-1A9E8ABD658AQ47921993-B263E0C2-C5E0-452F-89C6-FDDE6A094F27Q48342973-187033FB-A405-4757-8F23-C68E56AD8899Q48360098-EBECC3CA-2622-4FE1-8E22-6A9B14319A5CQ48397463-1CEBBE6A-D1B2-4064-B815-DBD195C463A9Q48500867-5F054C0B-CF41-4904-A1CE-50EAD8F8DD7AQ48630702-1E84BCD4-2DA7-42A0-89FC-66500636BE36Q49042013-DE90C744-8568-4CC3-92D1-63E1CC3F8FC8Q49127056-53C7DE3F-79AC-46B4-A188-B21E1CB08770Q51091115-0D78D5A4-F76F-428F-8FAA-F430CFAE15A9Q51899335-9D325312-30F5-472C-AEB2-63A817F6B8A6
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Carmen Pérez-García
@ast
Carmen Pérez-García
@en
Carmen Pérez-García
@es
Carmen Pérez-García
@nl
Carmen Pérez-García
@sl
type
label
Carmen Pérez-García
@ast
Carmen Pérez-García
@en
Carmen Pérez-García
@es
Carmen Pérez-García
@nl
Carmen Pérez-García
@sl
prefLabel
Carmen Pérez-García
@ast
Carmen Pérez-García
@en
Carmen Pérez-García
@es
Carmen Pérez-García
@nl
Carmen Pérez-García
@sl
P1053
K-2377-2014
P106
P21
P31
P3829
P496
0000-0003-4441-0071